6550--NEW - Access BNP Reagents
Closed Solicitation Posted
- Solicitation number
- 36C25722Q0129
- Agency
- Veterans Integrated Service Network 17 Veterans Health Administration, Department of Veterans Affairs
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Place of performance
- Department of Veterans Affairs South Texas Veterans Health Care System San Antonio, Texas 78229, United States
Notice details come from SAM.gov. Updated .
About this opportunity
The Department of Veterans Affairs South Texas Veterans Health Care System seeks to award a firm-fixed price supply contract for Access BNP Reagents compatible with Beckman Immunochemistry Instrumentation. The reagents are required to quantitatively measure B-Type Natriuretic peptide to diagnose and monitor patients with congestive heart disease and heart failure. Proposals must be submitted electronically to Ognian Ivanov by 10:00 AM Central Time on December 20, 2021. Award will be made on a single award basis to fulfill the continued need for this sole FDA-approved test to support care of COVID-19 patients at the agency.
There is no set-aside designation. The solicitation requires one item, Access BNP test kits containing 100 units, manufactured by Beckman Coulter. The place of performance is 7400 Merton Minter, San Antonio, TX 78229. Award is anticipated to fulfill the continued need for the sole FDA-approved BNP test, which is required to quantitatively measure BNP levels and support the diagnosis and monitoring of heart conditions in COVID-19 patients at the South Texas Veterans Health Care System location.
Notice text
The Department of Veterans Affairs South Texas Veterans Health Care System (STVHCS), Audie L. Murphy Division and the VISN 17 Contracting (10N17/671C), 7400 Merton Minter, San Antonio, TX 78229, intends to award a firm-fixed price supply contract, for the Access BNP Reagents compatible with the Beckman Immunochemistry Instrumentation. No other types of substitute or third-party reagents will fit the need of the STVHCS for the reasons notated. BNP is one of the analytes being monitored in COVID patients in the current Pandemic. The Access BNP test is the only BNP test approved by the FDA that is exclusively made to work on our current Beckman Coulter Immunochemistry Analyzers. The BNP test is an In Vitro quantitative measurement of B-Type Natriuretic peptide (BNP) used by physicians to diagnose Congestive Heart Disease (CHD), make treatment decisions and monitor patients with Heart Failure and Acute Coronary Syndrome
Please see attachment.
Please submit all information and proposals to Ognian Ivanov mailto:ognian.ivanov@va.gov no later than Monday , December 20, 2021, 11:00 AM ET (10:00 AM CT).
Attachments
| File | Type | Posted |
|---|---|---|
| 36C25722Q0129_1.docx | DOCX document | |
| 36C25722Q0129.pdf |
On GovTribe
Work this opportunity on GovTribe
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity